- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Liquidia Technologies Inc (LQDA)
Assess today's live Liquidia Technologies Inc (LQDA) share price, performance and insights using our live NASDAQ: LQDA stock exchange data.
Analyse the historical data and Liquidia Technologies Inc share price performance charts on this page. Our technical summary section provides analysis on Liquidia Technologies share price buy/sell indicators using real-time data (or discuss the Liquidia Technologies (LQDA) stock price today with other investors in the Liquidia Technologies NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ LQDA share price (ISIN: US53635D2027) to enhance your trading decisions with our free investment tools and resources.
What Is the Liquidia Technologies Inc Share Price Today?
The Liquidia Technologies share price today is 38.140.
What Is the Stock Symbol for Liquidia Technologies Inc
The stock symbol (or 'ticker') for Liquidia Technologies Inc is "LQDA."
What Stock Exchange Does Liquidia Technologies Inc Trade On?
Liquidia Technologies Inc is listed and trades on the NASDAQ stock exchange.
Is Liquidia Technologies Inc a Good Stock to Buy?
Determining whether Liquidia Technologies Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Liquidia Technologies Inc share price performance charts on this page. Our technical summary section provides analysis on Liquidia Technologies share price buy/sell indicators using real-time data (or discuss the Liquidia Technologies (LQDA) stock price today with other investors in the Liquidia Technologies NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ LQDA share price (ISIN: US53635D2027) to enhance your trading decisions with our free investment tools and resources.
What Is the Liquidia Technologies Inc Share Price Today?
The Liquidia Technologies share price today is 38.140.
What Is the Stock Symbol for Liquidia Technologies Inc
The stock symbol (or 'ticker') for Liquidia Technologies Inc is "LQDA."
What Stock Exchange Does Liquidia Technologies Inc Trade On?
Liquidia Technologies Inc is listed and trades on the NASDAQ stock exchange.
Is Liquidia Technologies Inc a Good Stock to Buy?
Determining whether Liquidia Technologies Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
38.030
39.270
52 wk Range
11.850
46.670
Earnings results expected in 5 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
38.03039.270
52 wk Range
11.85046.670
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LQDA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
50.667
Upside
+32.84%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
- Liquidia corp (LQDA) CBO Adair sells $280k in shares
- Investing.com
- Form 144 LIQUIDIA CORPORATION For: 17 April
- Investing.com
- Liquidia Corp CCO Moomaw sells $404k in shares
- Investing.com
- Liquidia Corp CEO Jeffs sells $2.14 million in stock
- Investing.com
- Form 144 LIQUIDIA CORPORATION For: 17 April
- Investing.com
- Liquidia Corp CEO Jeffs sells $2.14 million in stock
- Investing.com
- Liquidia Corp CFO Kaseta sells shares worth $5.7m
- Investing.com
- Form 144 LIQUIDIA CORPORATION For: 16 April
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Analyst Ratings
8 Buy
0 Hold
1 Sell
Ratings:
9 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 50.667
(+32.84% Upside)
Liquidia Technologies Inc Earnings Call Summary for Q4/2025
- Q4 2025 revenue hit $92.02M, beating forecasts by 8.51%; EPS of $0.15 missed expectations of $0.19, triggering 6.34% pre-market stock decline
- YUTREPIA captured 17% inhaled treprostinil market share, up from 10% prior quarter; maintained 89% gross margins with $190.7M year-end cash
- Generated $33M positive operating cash flow in Q4; reported $14.6M net income despite profitability concerns from EPS miss
- Guidance projects Q1 2026 EPS of $0.43 and Q2 EPS of $0.62; executives emphasize cost optimization and strategic market expansion initiatives
- CEO highlights YUTREPIA's market strength; faces challenges from competitive pressures, cost management issues, and regulatory scrutiny risks
Last Updated: 05/03/2026, 14:32
Read Full TranscriptEarnings
Latest Release
05/03/2026
EPS / Forecast
0.15 / 0.19
Revenue / Forecast
92.02M / 84.8M
Compare LQDA to Peers and Sector
Metrics to compare | LQDA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLQDAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −49.2x | −7.2x | −0.5x | |
PEG Ratio | −0.96 | −0.06 | 0.00 | |
Price/Book | 75.8x | 3.6x | 2.6x | |
Price / LTM Sales | 21.4x | 9.9x | 3.2x | |
Upside (Analyst Target) | 41.5% | 36.1% | 47.8% | |
Fair Value Upside | Unlock | 14.1% | 6.7% | Unlock |
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company’s lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also provides Remodulin, a treprostinil injection administered through continuous intravenous and subcutaneous infusion; and develops L606, an investigational liposomal formulation of treprostinil which is in phase III clinical trial for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). In addition, the company offers PRINT technology which allows to engineer and manufacture uniform drug particles with precise control over the size, three-dimensional geometric shape, and chemical composition of the particles. It has a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD; Vectura; The University of North Carolina at Chapel Hill; GlaxoSmithKline; Alcon Inc; and promotion Agreement with Sandoz. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Liquidia Technologies (NASDAQ: LQDA) Share Price Today?
The Liquidia Technologies stock price today is 38.140 USD.
What Stock Exchange Does Liquidia Technologies (LQDA) Trade On?
Liquidia Technologies is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Liquidia Technologies?
The stock symbol (also called a 'ticker') for Liquidia Technologies is "LQDA."
What Is the Current Liquidia Technologies Market Capitalisation?
As of today, Liquidia Technologies (NASDAQ: LQDA) market cap is 3.390B USD.
What Is Liquidia Technologies's (LQDA) Earnings Per Share (TTM)?
The Liquidia Technologies EPS is currently -0.801 (Trailing Twelve Months).
When Is the Next Liquidia Technologies Earnings Date?
Liquidia Technologies's next earnings report will be released on 07/05/2026.
Is LQDA a Buy or Sell From a Technical Analyst Perspective?
Based on today's Liquidia Technologies moving averages and other technical indicators, the daily buy/sell signal for LQDA stock is Buy.
How Many Times Has Liquidia Technologies Stock Split?
Liquidia Technologies has split 0 times. (See the LQDA stock split history page for full effective split date and price information.)
How Many Employees Does Liquidia Technologies Have?
Liquidia Technologies has 216 employees, based on their latest Companies House report.
What is the current trading status of Liquidia Technologies (NASDAQ: LQDA)?
As of 02/05/2026, Liquidia Technologies (LQDA) is trading at a share price of 38.140 USD, with a previous close of 39.210 USD. The stock has fluctuated within a day range of 38.030 USD to 39.270 USD, while its 52-week range spans from 11.850 USD to 46.670 USD.
What Is Liquidia Technologies (LQDA) Price Target According to Analysts?
The average 12-month price target for Liquidia Technologies is 50.667 USD, with a high estimate of 67 USD and a low estimate of 19 USD. 8 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +32.84% Upside potential.
What Is the LQDA Premarket Price?
LQDA's last pre-market stock price is 39.500 USD. The pre-market share volume is 10.000, and the stock has decreased by 0.290, or 0.740%.
What Is the LQDA After Hours Price?
LQDA's last after hours stock price is 39.500 USD, the stock has decreased by 1.360, or 3.570%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.